Acquired Brand CTK Biotech operates as a brand under SSI Diagnostica Group, indicating potential cross-sell opportunities to SSI’s global customer base and access to SSI’s distribution channels and sales infrastructure.

Global Reach As part of SSI Diagnostica Group with offices across Denmark, the US, and China and presence in over 130 countries, there are expansive geographic sales opportunities for CTK Biotech’s tests and related diagnostics solutions.

Infectious Disease Focus SSI Diagnostica’s four disease focus areas align with CTK Biotech’s immunofluorescence and rapid testing capabilities, suggesting targeted upsell around gastric, respiratory, bloodborne, and general microbiology diagnostics.

Growth Potential Revenue in the low-mid single digits with a lean team (51-200 employees) signals a scalable opportunity when paired with SSI’s larger sales force and product portfolio to accelerate market penetration.

Recent Collaborations Past partnerships and the 2020 closed-system launch indicate a receptiveness to integrated diagnostic solutions, presenting a door for bundled offerings, system integrations, and co-marketed campaigns.